Nanovibronix (NAOV) Competitors $5.57 -0.25 (-4.30%) Closing price 04:00 PM EasternExtended Trading$5.63 +0.06 (+1.08%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock NAOV vs. AMIX, STSS, QNRX, PTHL, TIVC, CHEK, NDRA, VERO, AEMD, and GCTKShould you be buying Nanovibronix stock or one of its competitors? The main competitors of Nanovibronix include Autonomix Medical (AMIX), Sharps Technology (STSS), Quoin Pharmaceuticals (QNRX), Pheton (PTHL), Tivic Health Systems (TIVC), Check-Cap (CHEK), ENDRA Life Sciences (NDRA), Venus Concept (VERO), Aethlon Medical (AEMD), and GlucoTrack (GCTK). These companies are all part of the "medical equipment" industry. Nanovibronix vs. Its Competitors Autonomix Medical Sharps Technology Quoin Pharmaceuticals Pheton Tivic Health Systems Check-Cap ENDRA Life Sciences Venus Concept Aethlon Medical GlucoTrack Autonomix Medical (NASDAQ:AMIX) and Nanovibronix (NASDAQ:NAOV) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation. Do insiders and institutionals believe in AMIX or NAOV? 10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 16.4% of Nanovibronix shares are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by company insiders. Comparatively, 6.3% of Nanovibronix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, AMIX or NAOV? Autonomix Medical has a beta of -2.96, indicating that its stock price is 396% less volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500. Do analysts recommend AMIX or NAOV? Autonomix Medical currently has a consensus target price of $16.50, indicating a potential upside of 1,400.00%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Nanovibronix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Nanovibronix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is AMIX or NAOV more profitable? Autonomix Medical has a net margin of 0.00% compared to Nanovibronix's net margin of -380.29%. Nanovibronix's return on equity of -45.24% beat Autonomix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Autonomix MedicalN/A -172.93% -133.39% Nanovibronix -380.29%-45.24%-34.24% Does the media favor AMIX or NAOV? In the previous week, Autonomix Medical had 4 more articles in the media than Nanovibronix. MarketBeat recorded 5 mentions for Autonomix Medical and 1 mentions for Nanovibronix. Nanovibronix's average media sentiment score of 1.87 beat Autonomix Medical's score of 0.70 indicating that Nanovibronix is being referred to more favorably in the news media. Company Overall Sentiment Autonomix Medical Positive Nanovibronix Very Positive Which has preferable earnings & valuation, AMIX or NAOV? Nanovibronix has higher revenue and earnings than Autonomix Medical. Nanovibronix is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutonomix MedicalN/AN/A-$11.41M-$5.74-0.19Nanovibronix$2.34M0.61-$3.70M-$13.53-0.41 SummaryAutonomix Medical beats Nanovibronix on 8 of the 15 factors compared between the two stocks. Get Nanovibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAOV vs. The Competition Export to ExcelMetricNanovibronixMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.44M$6.94B$5.76B$9.84BDividend YieldN/A1.30%3.95%4.03%P/E Ratio-0.4126.3631.3126.60Price / Sales0.6156.55461.61121.39Price / CashN/A21.6137.7659.36Price / Book0.046.9110.026.67Net Income-$3.70M$176.42M$3.27B$265.59M7 Day Performance10.74%3.69%3.17%3.42%1 Month Performance-39.31%-1.34%4.34%1.09%1 Year Performance-91.18%10.18%44.12%23.84% Nanovibronix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAOVNanovibronix0.6735 of 5 stars$5.57-4.3%N/A-91.2%$1.44M$2.34M-0.4120Negative NewsAMIXAutonomix Medical2.8523 of 5 stars$1.12-0.9%$16.50+1,373.2%-90.0%$5.81MN/A-0.201STSSSharps Technology1.3782 of 5 stars$5.06+1.8%N/AN/A$5.09MN/A0.003News CoverageInsider TradeGap UpQNRXQuoin Pharmaceuticals0.9794 of 5 stars$7.15-4.4%N/A-64.5%$4.40MN/A-0.174Gap DownHigh Trading VolumePTHLPhetonN/A$0.64+1.2%N/AN/A$4.16M$450K0.0011Positive NewsGap UpTIVCTivic Health Systems0.5318 of 5 stars$3.31-12.7%N/A-47.8%$4.10M$780K0.0010Gap DownCHEKCheck-Cap0.6796 of 5 stars$0.66-0.6%N/A-66.3%$3.89MN/A-0.2280NDRAENDRA Life Sciences2.9237 of 5 stars$4.82-0.8%$50.00+937.3%-76.9%$3.66MN/A-0.1420Gap DownVEROVenus Concept0.6401 of 5 stars$2.32flatN/A-65.5%$3.30M$64.83M-0.05410AEMDAethlon Medical2.5204 of 5 stars$1.17+2.6%$56.00+4,686.3%-58.2%$2.96M$570K-0.0910GCTKGlucoTrack0.4849 of 5 stars$5.72-0.9%N/A-99.9%$2.75MN/A-0.105Gap Down Related Companies and Tools Related Companies Autonomix Medical Competitors Sharps Technology Competitors Quoin Pharmaceuticals Competitors Pheton Competitors Tivic Health Systems Competitors Check-Cap Competitors ENDRA Life Sciences Competitors Venus Concept Competitors Aethlon Medical Competitors GlucoTrack Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAOV) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanovibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanovibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access